Publications

When financial markets weaken, smart investors with a long-term perspective make highly strategic buys. They know that when the inevitable upturn occurs the carefully targeted investments that they made during lean times will pay off handsomely. Indeed, those investments will be seen in retrospect as a great bargain and the investors as having had great foresight. Human resources leaders and executives with P&L responsibility would be well-advised to adopt a similar strategy with talent acquisition.

This is the fifth edition of Egon Zehnder International’s annual biotech survey, based on interviews with a broad selection of senior executives, non-executives and investors in the European sector of the industry. 

This year’s survey focuses on what companies can do to help ensure that they have an effective board. Of course this is hardly a topic of exclusive relevance to biotechnology businesses.